Cargando…
Tanezumab: Finally a Monoclonal Antibody for Pain Relief
Autor principal: | Nair, Abhijit S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6069623/ https://www.ncbi.nlm.nih.gov/pubmed/30111960 http://dx.doi.org/10.4103/IJPC.IJPC_208_17 |
Ejemplares similares
-
Response to: “Tanezumab: Therapy targeting nerve growth factor in pain pathogenesis”
por: Tive, Leslie A., et al.
Publicado: (2018) -
Tanezumab: Therapy targeting nerve growth factor in pain pathogenesis
por: Patel, Mona K., et al.
Publicado: (2018) -
Erector spinae plane block: a new modality of pain relief in a difficult situation
por: Rajmohan, Nisha, et al.
Publicado: (2021) -
Chronic pain and pain relief by extracorporeal shock wave therapy
por: Wess, Othmar J.
Publicado: (2011) -
Population pharmacokinetics of tanezumab in phase 3 clinical trials for osteoarthritis pain
por: Jonsson, E. Niclas, et al.
Publicado: (2016)